StockData
Vyome Holdings, Inc logo

Vyome Holdings, Inc (HIND) stock

HINDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 1/30
$1.51−0.03 (-2.27%)

Close on Nov 18, 2026Market cap $10.60MP/E –Yield –

Vyome net income

Net income is the profit left for shareholders after every expense, interest and tax.

Vyome's net income for the twelve months ending Jun 30, 2026 was -$11.31M. For fiscal 2025 it was -$10.26M. The highest annual figure on record is -$1.45M in fiscal 2024.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$10.26M–
FY2024Dec 31, 2024-$1.45M–
FY2023Dec 31, 2023-$11.39M–
FY2022Dec 31, 2022-$46.21M–
FY2021Dec 31, 2021-$63.15M–
FY2020Dec 31, 2020-$21.63M–
FY2019Dec 31, 2019-$23.68M–
FY2018Dec 31, 2018-$37.38M–
FY2017Dec 31, 2017-$34.77M–
FY2016Dec 31, 2016-$20.47M–
FY2015Dec 31, 2015-$15.56M–
FY2014Dec 31, 2014-$9.89M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$685.56K–
Q1 FY2026Mar 31, 2026-$962.91K–
Q4 FY2025Dec 31, 2025-$1.23M–
Q3 FY2025Sep 30, 2025-$8.43M–
Q2 FY2025Jun 30, 2025-$308.76K–
Q1 FY2025Mar 31, 2025-$293.97K–
Q4 FY2024Dec 31, 2024-$306.56K–
Q3 FY2024Sep 30, 2024-$547.77K–
Q2 FY2024Jun 30, 2024-$1.60M–
Q1 FY2024Mar 31, 2024-$2.19M–
Q4 FY2023Dec 31, 2023-$1.70M–
Q3 FY2023Sep 30, 2023-$3.53M–
Q2 FY2023Jun 30, 2023-$3.49M–
Q1 FY2023Mar 31, 2023-$2.66M–
Q4 FY2022Dec 31, 2022-$16.47M–
Q3 FY2022Sep 30, 2022-$12.19M–
Q2 FY2022Jun 30, 2022-$9.44M–
Q1 FY2022Mar 31, 2022-$8.12M–
Q4 FY2021Dec 31, 2021-$37.25M–
Q3 FY2021Sep 30, 2021-$17.13M–
Q2 FY2021Jun 30, 2021-$3.89M–
Q1 FY2021Mar 31, 2021-$4.87M–
Q4 FY2020Dec 31, 2020-$8.54M–
Q3 FY2020Sep 30, 2020-$5.18M–
Q2 FY2020Jun 30, 2020-$3.60M–
Q1 FY2020Mar 31, 2020-$5.26M–
Q4 FY2019Dec 31, 2019-$4.91M–
Q3 FY2019Sep 30, 2019-$3.71M–
Q2 FY2019Jun 30, 2019-$6.77M–
Q1 FY2019Mar 31, 2019-$8.29M–
Q4 FY2018Dec 31, 2018-$8.76M–
Q3 FY2018Sep 30, 2018-$6.75M–
Q2 FY2018Jun 30, 2018-$9.75M–
Q1 FY2018Mar 31, 2018-$12.13M–
Q4 FY2017Dec 31, 2017-$10.12M–
Q3 FY2017Sep 30, 2017-$9.17M–
Q2 FY2017Jun 30, 2017-$7.73M–
Q1 FY2017Mar 31, 2017-$7.75M–
Q4 FY2016Dec 31, 2016-$7.50M–
Q3 FY2016Sep 30, 2016-$5.26M–

More Vyome figures

See a number that looks wrong?